| |
| |
|
| Insider
Information: |
Cohen Marc A |
| Relationship: |
Director |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
18,975 |
|
|
Indirect Shares
|
2,580,083 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,599,058 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Korro Bio |
KRRO |
Director |
2020-01-30 |
17,857 |
2020-01-30 |
605,820 |
Premium* |
|
|
C4 Therapeutics, Inc. |
CCCC |
Director |
2022-01-04 |
1,118 |
2022-01-04 |
1,974,263 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-01-04 |
4 |
A |
$31.58 |
$20,748 |
D/D |
657 |
1,118 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-10-04 |
4 |
A |
$44.99 |
$20,740 |
D/D |
461 |
461 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-07-02 |
4 |
A |
$39.72 |
$20,734 |
D/D |
522 |
6,641 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
22,598 |
1,874,805 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
92,817 |
98,936 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • • |
2021-02-18 |
4 |
OE |
$2.11 |
$1,131 |
D/D |
536 |
5,566 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
4,203,757 |
2,484,425 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • • |
2020-10-06 |
4 |
B |
$19.00 |
$95,570 |
D/D |
5,030 |
5,030 |
3.92 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
132,875 |
|
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2020-01-30 |
4 |
OE |
$0.61 |
$228,688 |
I/I |
88,116 |
605,820 |
0 |
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2019-10-07 |
4 |
B |
$14.00 |
$249,998 |
D/D |
17,857 |
17,857 |
2.39 |
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2019-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
445,229 |
517,704 |
0 |
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
72,475 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
